| 查看: 2171 | 回复: 41 | |||
| 【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 123n 的 24 个金币 ,回帖就立即获得 2 个金币,每人有 1 次机会 | |||
[交流]
美国芝加哥大学Zhou Lab招聘化学,化学生物学,或者抗体/蛋白质工程背景博后
|
|||
|
Position Title: Postdoc in Chemical Biology and Protein/Antibody Engineering Division/Department: Biological Sciences Division; Department of Radiation and Cellular Oncology; Department of Chemistry Faculty Sponsor: Jie Zhou, Ph.D. Assistant Professor Lab introduction The Zhou Lab at the University of Chicago is seeking an enthusiastic and dedicated Postdoctoral Researcher with a strong interest in the development of targeted immunotherapies with chemical biology and protein/antibody engineering approaches. We work at the vibrant interface of chemistry and biology, with a specific focus on the complex dynamics of cell surfaces within the tumor microenvironment (TME). This interdisciplinary position presents an excellent opportunity for a Ph.D. graduate seeking to make significant contributions to the field of protein/antibody engineering & immunotherapy. This position offers an opportunity to work in a dynamic, collaborative environment within the Department of Radiation & Cellular Oncology and the Department of Chemistry at the University of Chicago. You'll work closely with Dr. Zhou, who has extensive experience and training in peptide chemistry, chemical biology, protein/antibody/cell engineering, and immunotherapy. The Zhou Lab is also part of the University of Chicago Comprehensive Cancer Center, offering additional opportunities for collaborative research and career development. For more information: https://voices.uchicago.edu/jzhoulab/research-2/ https://biologicalsciences.uchicago.edu/faculty/jie-zhou https://chemistry.uchicago.edu/faculty/jie-zhou Projects and technologies The successful candidate will be integral to our ongoing research projects, with a focus on: • Elucidating new chemical and biological phenomena or mechanisms on cell membranes contributing to pathological phenotypes. • Harnessing these insights to drive the development of next-generation immunotherapies. • Engineering small molecules and biologics to enhance our understanding of diseases and facilitate the creation of innovative therapeutics. The potential candidate will employ a diverse range of methodologies/technologies, including synthetic chemistry, proteomics, functional genomics, and protein/antibody/cell engineering. They will also leverage combinatorial selection technologies such as phage/yeast/cell/virus display, coupled with next-generation sequencing (NGS) and bioinformatics, to advance biological research. Qualification The selected individual is expected to proficiently manage multiple and competing projects and to maintain comprehensive and clear research notes. The successful candidate should be capable of presenting their research progress in internal group meetings and external scientific seminars to the broader scientific community within and outside the University of Chicago. We are seeking candidates who are highly independent, resourceful, and passionate about pioneering cancer immunotherapies. A Ph.D. or educational equivalent required Ph.D. in chemistry, chemical biology or biochemistry are preferred. Organic chemistry background OR experience of molecular biology experiments, such as cloning, protein expression and purification, is appreciated. Knowledge of basic immunological concepts is appreciated. Experience in combinatorial selection technologies, next-generation sequencing (NGS), and bioinformatics is highly desirable. Ability to write and verbalize clear and complete research findings in the English language. Demonstrated ability to work independently and as a team member. Benefit Compensation in the Biological Sciences Division follows the NIH NRSA Stipend scale. Additional information on benefits and being a postdoc in the University of Chicago Biological Sciences Division can be found at https://bsdpostdoc.uchicago.edu/. The University of Chicago is an Affirmative Action/Equal Opportunity/Disabled/Veterans Employer Contact Motivated candidates should submit a CV with names of 2-3 referees to Dr. Jie Zhou at jiezhou6@uchicago.edu. We look forward to your application and the potential to welcome you to our team. |
» 猜你喜欢
面上没中,邀请各位路过的虫友分析一下分数
已经有7人回复
哈尔滨工业大学韩晓军教授课题组招收2027年硕士推免生及博士研究生
已经有3人回复
找导师
已经有8人回复
国社科又开始会评了,不知道这次命运如何
已经有14人回复
麻烦专家们看看评委们的意见(F口面上)
已经有13人回复
科研人应该花精力去思考如何解决问题,而不是去凝练问题
已经有14人回复
要骂人了,新模版改版就是要淡化问题凝练这种虚的东西,结果有个评委还在说凝练得不够
已经有17人回复
学科评审组评审是指会评吗?
已经有5人回复
小白求助 投论文要求的highlights应该如何写
已经有4人回复
面上意见出来了
已经有23人回复
13楼2023-10-25 13:22:08
8楼2023-10-25 09:29:28
18楼2023-10-25 18:15:16
chenhuanlong
禁虫 (文学泰斗)
★
123n(金币+2): 谢谢参与
123n(金币+2): 谢谢参与
|
本帖内容被屏蔽 |
19楼2023-10-25 18:44:15
24楼2023-10-26 02:51:27
26楼2023-10-26 07:52:55
27楼2023-10-26 08:47:08
32楼2023-10-26 16:17:59
简单回复
2023-10-25 06:58
回复
123n(金币+2): 谢谢参与
2023-10-25 07:36
回复
123n(金币+2): 谢谢参与

kecikeci4楼
2023-10-25 08:00
回复
123n(金币+2): 谢谢参与
babero5楼
2023-10-25 08:34
回复
123n(金币+2): 谢谢参与
逍遥仙影6楼
2023-10-25 08:53
回复
123n(金币+2): 谢谢参与
2023-10-25 09:18
回复
123n(金币+2): 谢谢参与
2023-10-25 10:43
回复
123n(金币+2): 谢谢参与
xiaoqiuqiu2010楼
2023-10-25 10:54
回复
123n(金币+2): 谢谢参与
ckxbear11楼
2023-10-25 10:59
回复
123n(金币+2): 谢谢参与
jiaoxg12楼
2023-10-25 12:06
回复
123n(金币+2): 谢谢参与




啊哦呃咦呜吁14楼
2023-10-25 15:24
回复
123n(金币+2): 谢谢参与

dld12315楼
2023-10-25 16:08
回复
1
nono200916楼
2023-10-25 17:29
回复
123n(金币+2): 谢谢参与
·
hyjcs17楼
2023-10-25 17:56
回复
123n(金币+2): 谢谢参与
喔 发自小木虫Android客户端
心月孤悬20楼
2023-10-25 18:55
回复
123n(金币+2): 谢谢参与
凌雅琴集21楼
2023-10-25 19:08
回复
123n(金币+2): 谢谢参与
1 发自小木虫Android客户端
toppaper22楼
2023-10-25 19:21
回复
psylhh23楼
2023-10-25 23:24
回复
123n(金币+2): 谢谢参与
dld12325楼
2023-10-26 04:38
回复
123n(金币+2): 谢谢参与
1
tzynew28楼
2023-10-26 09:35
回复
123n(金币+2): 谢谢参与
guoqiang3029楼
2023-10-26 09:42
回复
假大空30楼
2023-10-26 11:51
回复
123n(金币+2): 谢谢参与
顶
yuanheqi31楼
2023-10-26 13:22
回复
123n(金币+2): 谢谢参与
1
XG-WUST33楼
2023-10-26 19:25
回复
123n(金币+2): 谢谢参与
up 发自小木虫IOS客户端
欣哲-21134楼
2023-10-26 19:53
回复
123n(金币+2): 谢谢参与
落花剑雨35楼
2023-10-27 01:23
回复
123n(金币+2): 谢谢参与
123n36楼
2023-10-30 06:28
回复






wwwmail_li37楼
2023-10-31 10:59
回复
123n(金币+2): 谢谢参与
bjdxyxy38楼
2024-07-19 11:30
回复
123n(金币+2): 谢谢参与
。。 发自小木虫Android客户端
luzhuolin39楼
2024-07-19 14:55
回复
123n(金币+2): 谢谢参与
licheng7840楼
2024-07-21 15:44
回复
123n(金币+2): 谢谢参与

Doncic198941楼
2024-07-22 11:34
回复
biology-jlu42楼
2024-07-22 17:07
回复
123n(金币+2): 谢谢参与










回复此楼

